Xtl Biopharmaceuticals (XTLB) Selling, General & Administrative (2009 - 2024)
Xtl Biopharmaceuticals (XTLB) reported Selling, General & Administrative of -$1.44 million for the year ended Dec 31, 2025, compared with -$759,000 a year earlier.
Powered by 
Analysis
Xtl Biopharmaceuticals (XTLB) Selling, General & Administrative (2009 - 2024) Analysis & Trends
Dating back to the year ended Dec 31, 2009, Xtl Biopharmaceuticals' Selling, General & Administrative record includes 17 years.
- The figure for the year ended Dec 31, 2025 ranks as the lowest annual Selling, General & Administrative since the year ended Dec 31, 2014.
- According to Business Quant data, Selling, General & Administrative came in at -$759,000 in the year ended Dec 31, 2024, -$734,000 in the year ended Dec 31, 2023, -$850,000 in the year ended Dec 31, 2022 and -$1 million in the year ended Dec 31, 2021.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | SG&A (Qtr) |
|---|---|---|---|---|---|
| 1 | Eli Lilly | 1,082.65 Bn | 1,051.23 Bn | 19.71 Bn | 3.43 Bn |
| 2 | Johnson & Johnson | 623.68 Bn | 542.21 Bn | 17.26 Bn | 6.43 Bn |
| 3 | AbbVie | 459.43 Bn | 432.59 Bn | 12.70 Bn | 3.63 Bn |
| 4 | Merck | 354.80 Bn | 309.23 Bn | 12.21 Bn | 2.90 Bn |
| 5 | Novartis Ag | 269.16 Bn | 225.03 Bn | 11.24 Bn | -3.24 Bn |
| 6 | Astrazeneca | 244.40 Bn | 217.97 Bn | 12.86 Bn | -5.65 Bn |
| 7 | Amgen | 220.17 Bn | 175.57 Bn | 7.24 Bn | 1.75 Bn |
| 8 | Gilead Sciences | 183.05 Bn | 157.16 Bn | 6.22 Bn | 1.92 Bn |
| 9 | Pfizer | 160.27 Bn | 107.22 Bn | 10.94 Bn | 3.41 Bn |
| 10 | Xtl Biopharmaceuticals | 2.13 Bn | 2.13 Bn | - | - |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Dec 31, 2024 | 297,000.00 |
| Sep 30, 2024 | -472,000.00 |
| Jun 30, 2024 | -415,000.00 |
| Mar 31, 2024 | -169,000.00 |
| Dec 31, 2023 | -194,000.00 |
| Sep 30, 2023 | -145,000.00 |
| Jun 30, 2023 | -157,000.00 |
| Mar 31, 2023 | -238,000.00 |
| Dec 31, 2022 | -219,000.00 |
| Sep 30, 2022 | -201,000.00 |
| Jun 30, 2022 | -187,000.00 |
| Mar 31, 2022 | -243,000.00 |
| Dec 31, 2021 | -280,000.00 |
| Sep 30, 2021 | -204,000.00 |
| Jun 30, 2021 | -297,000.00 |
| Mar 31, 2021 | -220,000.00 |
| Dec 31, 2020 | -245,000.00 |
| Sep 30, 2020 | -205,000.00 |
| Jun 30, 2020 | -206,000.00 |
| Mar 31, 2020 | -254,000.00 |
API Access
Xtl Biopharmaceuticals Selling, General & Administrative API
Pull this series into your own models, spreadsheets and apps with the Business Quant
Historical Metrics API. The request below matches the chart above — change the
frequency, period or values and it follows. Swap YOUR_API_KEY for your own key.
https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=XTLB&period=max&api_key=YOUR_API_KEYimport requests
url = "https://data.businessquant.com/historic"
params = {"slug": "selling-general-and-administrative", "ticker": "XTLB", "period": "max", "api_key": "YOUR_API_KEY"}
data = requests.get(url, params=params).json()const res = await fetch("https://data.businessquant.com/historic?slug=selling-general-and-administrative&ticker=XTLB&period=max&api_key=YOUR_API_KEY");
const data = await res.json();